(Klemperer 2010) Drug research: marketing before evidence, sales before safety


Klemperer, David. Drug research: marketing before evidence, sales before safety [editorial]. Deutsches Ärzteblatt International. 2010 Apr; 107(16):277–278. Available from: http://dx.doi.org/10.3238/arztebl.2010.0277. Accessed 2012 Apr 15. Archived by WebCite at http://www.webcitation.org/66wQn7w2Y.

Klemperer describes a pattern of biased results in clinical drug trials funded by pharmaceutical companies, facilitated by lack of transparency about study protocols, endpoints to be evaluated, and data.

 

Shortlink to this page: http://is.gd/ioout8
Last revision: April 5, 2013